Abstract:A scary viral pneumonia (COVID-19) has recently engulfed the globe. The new strain of the virus, named SARS-CoV-2, belongs to the coronavirus family, so research aims to screen multimodal structure-based structure-design of ligands and drugs and then docked to the main viral protease to investigate the active binding sites. A new 3-acetyl-7-hydroxy coumarin (HL) and its Cu(II), Ni(II), Zn(II), and Mn(II) complexes have been formed and characterized by elemental analysis, IR, 1H NMR, and UV visible spectra, as well as magnetic and thermal measurements. Molar conductance experiments have shown that all complexes are non-ionic or non-electrolytes. IR spectra show that the ligand (HL) behaves as a bidentate monobasic ligand coordinating via the oxygen atom of the deprotonated phenolic -OH group and the nitrogen atom of the azo group (-N=N-), forming a six-member chelating ring. The molecular and electronic structures of the investigated compounds were also analyzed using quantum chemical calculations. The complexes’ thermal decomposition exposed the outer and inner water molecules as well as the end product, which is mainly metal oxide. The thermodynamic parameter ligand (HL) and its metal complexes are calculated using the Coats-Redfern and Horowitz Metzger methods. Using absorption spectra, the ligand (HL) binding behavior of the calf thymus DNA and its metal complexes were studied. A molecular docking simulation computational method is performed to screen the antiviral activity of drugs, natural drug activity, sources, and anti-SARS-CoV-2 genome inhibitory compounds. The primary virus protease collected from a Bank of Protein Data (PDB# 6YB7) and docked with a sequence of HL and its complexes. On the other hand, the prediction of binding between azo compound with the breast cancer receptor 3hb5-oxidoreductase and the prostate cancer mutant 2q7k – hormone was also made. The docking results were promised and indicated that the reported ligand can firmly bind to the SARS-CoV-2, breast, and prostate cancer leads to inhibition of its infectious impact. The cytotoxic activity of ligand (HL) and its metal complexes was tested against human cancer MCF-7 (breast cancer).

Molecular Docking Simulation based Virtual Screening for The Design of Potential Inhibitors of Heme Oxygenase of Corney Bacterium Diphtheria

Identification of potential inhibitors against Corynebacterium diphtheriae MtrA response regulator protein; an in-silico drug discovery approach

Molecular recognition of bio-active triterpenoids from Swertia chirayita towards hepatitis Delta antigen: a mechanism through docking, dynamics simulation, Gibbs free energy landscape

In Silico Molecular Docking and Simulation Studies of Protein HBx Involved in the Pathogenesis of Hepatitis B Virus-HBV

Molecular Docking Study of the Cytochrome BC1 Complexed with Inhibitors

Thermal and Spectroscopic Studies of Some Prepared Metal Complexes and Investigation of their Potential Anticancer and Antiviral Drug Activity against SARS-CoV-2 by Molecular Docking Simulation

Computational design of prospective molecular targets for Burkholderia cepacia complex by molecular docking and dynamic simulation studies

Development of a Human Dihydroorotate Dehydrogenase (hdhodh) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.

Molecular docking based screening of a simulated HIF-1 protein model for potential inhibitors

Molecular Docking and Dynamic Simulation Studies of Benzoylated Emodin into HBV Core Protein

Docking Studies of N-alkylated Indole Derivatives with Mycobacterium Enoyl Acyl Carrier Protein Reductase (Inh A) as Potent Antitubercular Agents

Computational Exploration of Isatin Derivatives for InhA Inhibition in Tuberculosis: Molecular Docking, MD Simulations and ADMET Insights

Discovery of Thiadiazoles as Human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors by Combined Structure‐Based Modelling Methods

In silico homology modeling of dengue virus non-structural 4B (NS4B) protein and its molecular docking studies using triterpenoids

Identification of a Chemical Inhibitor with a Novel Scaffold Targeting Decaprenylphosphoryl-β-D-Ribose Oxidase (DprE1)

Investigating the binding affinity, molecular dynamics, and ADMET properties of 2,3-dihydrobenzofuran derivatives as an inhibitor of fungi, bacteria, and virus protein

Computational Modelling, Functional Characterization and Molecular Docking to Lead Compounds of Bordetella pertussis Diaminopimelate Epimerase

Discovery of newer pyrazole derivatives with potential anti-tubercular activity via 3D-QSAR based pharmacophore modelling, virtual screening, molecular docking and molecular dynamics simulation studies

Evaluation of novel pyridoxal isonicotinoyl hydrazone (PIH) derivatives as potential anti‐tuberculosis agents: An in silico investigation

MOLECULAR DOCKING DYNAMICS OF SELECTED BENZYLIDENE AMINO PHENYL ACETAMIDES AS TMK INHIBITORS USING HIGH THROUGHPUT VIRTUAL SCREENING (HTVS)

Computational screening of natural MtbDXR inhibitors for novel anti-tuberculosis compound discovery